Many diseases are characterized by muscle atrophy and inhibition of myostatin has emerged as an appealing therapeutic approach that alleviates overall muscle weakness and enhances the performance of daily activities, thus improving quality of life [16,23]. The gene discussed is MSTN; the disease is Atrophy.